The ERCC1 protein has been predicted to form part of a tight complex with a protein partner, the yet-unidentified XPF/ERCC4 protein, in normal human cells. We used an anti-ERCCl antibody to detect the complex by immunoprecipitation and immunoblotting. The amount of ERCC1 protein expressed in five different XP-F cell strains was 17 5-1/34 of that of the protein in normal and XP cell strains representing other complementation groups. A 120 kDa protein was co-immunoprecipitated with ERCC1 by the anti-ERCCl antibody, and the amount of the 120 kDa protein in XP-F cell strains was 1/5-1/8 of that of the protein in normal and XP cell strains representing other complementation groups. The XPA protein was not coimmunoprecipitated with ERCC1 in any cell strain. These results demonstrate that a low level of ERCC1 and the 120 kDa protein is a frequent feature of XP-F cell extracts and that a lower amount of a complex between these proteins occurs in XP-F cells than in normal cells.
Introduction
Xeroderma pigmentosum (XP) is an autosomal recessive hereditary disease characterized by hyperphotosensitivity and a high incidence of skin cancer development (Kraemer et al, 1987) . XP has been classified into seven human genetic complementation groups (A-G) of the nucleotide excision repair (NER)-deficient type and one variant of the NERproficient type. Most of the genes responsible for causing XP have been cloned, but the sequence of XPF has not been reported (Tanaka and Wood, 1994; Hoeijmakers, 1994) .
Rodent DNA repair-deficient mutant cells have been classified into 11 genetic complementation groups [Rodent Complementation Group (RCG) 1-11] (Hoeijmakers, 1993) . The human genes correcting rodent repair defects are called ERCC (Excision Repair Cross-Complementing) genes. ERCC1 is a gene complementing NER deficiency of RCG 1 cells (Van Duin et al, 1986) , and the ERCC1 gene product (31 kDa protein) is a human homologue of the Saccharomyces cerevisiae RadlO protein. RadlO makes a complex with Radl protein and has a structure-specific endonuclease activity (Bardwell etal, 1994) . By analogy with the S.cerevisiae Radl-RadlO complex, the human ERCC1 protein should bind to a Radl homologue. Products of the ERCC4 gene complementing rodent RCG4 cells (Thompson et al, 1994) or the XPF gene have been thought to be candidates for the Radl homologue although the isolation of corresponding cDNAs for these genes has not been reported. Estimates of the molecular mass of the ERCC 1-XPF complex have been made by hydrodynamic methods (Biggerstaff et al, 1993; Van Vuuren et al, 1993) and native gel electrophoresis (Van Vuuren et al, 1995) , and vary between 100 and 200 kDa.
There are several reports describing proteins bound to the ERCC1 protein. During chromatography of human HeLa cell protein, ERCC1 copurified with correcting activity for XP-F and RCG4 cell extracts (Biggerstaff et al, 1993; Van Vuuren et al, 1993) and with a band migrating at 110 kDa (Mu et al, 1995) . In a western blot experiment, a 110 kDa band bound to 125 I-labelled purified ERCC1 protein was detected in normal cell extract but not in XP-F cell extract (Aboussekhra et al, 1995) . An anti-ERCCl antibody co-immunoprecipitated a 120 kDa protein with the ERCC 1 protein from normal cell extract but not from XP-F cell extract (Van Vuuren et al, 1995) . A low ERCC1 protein content was observed in Chinese hamster RCG4 cells and XP-F cells, and DNA repair activity of the RCG4 or XP-F cell extracts was not complemented with RCG 1 cell extract but with cell extracts with other complementation groups in the in vitro DNA repair assay (Biggerstaff et al, 1993) . These results suggest that the 110-120 kDa protein makes a complex with ERCC1 protein. However, all these results were obtained from experiments using a single cell strain XP2YO(SV), which is the the only available immortal XP-F cell strain (Yagi and Takebe, 1983) .
In this study, we looked for proteins binding to ERCC1 in human cells by immunological methods. We found that a 120 kDa protein is co-immunoprecipitated with ERCC1 from normal cell extract by an anti-ERCCl antibody, but a lower amount of the protein is co-immunoprecipitated from extract of all XP-F cell strains tested. The XPA protein was not coimmunoprecipitated with ERCC 1 by an anti-ERCC 1 antibody in the extract of any cell, even though an association of XPA and ERCC1 has been demonstrated in vitro (Li et al, 1994; Park and Sancar, 1994; Nagai et al, 1995) .
Materials and methods
Normal human and XP cell strain;, were obtained from the American Type Culture Collection, NIGMS Human Genetic Mutant Cell Repository or established in our laboratory. The XP-F strain XP2YO is the untransformed original fibroblast cells of the Simian Virus 40-transformed XP2YO(SV) strain, and XP2YO and XP3Y0 patients are kindred. The XP-F pedigrees represented by XP2YO/3YO, XP101OS and XP7KA are unrelated. All cells were cultured in Dulbecco's modified minimum essential medium supplemented with 10* fetal bovine serum at 37°C in a CO2 incubator.
For the immunoblot, ~10 7 cells were lysed with RIPA buffer, consisting of 50 mM Tris-HCl (pH 7.2), 150 mM NaCl, 1% iN'P-40, \% sodium deoxycholate, 0.05% sodium dodecyl sulphate (SDS) and 10 mM phenylmethylsulphonyl fluoride (PMSF). Cell extract proteins (40 |ig/lane) were separated by electrophoresis in 12% SDS-polyacrylamide gels and transferred to the Hybond C Extra (Amersham, UK) membrane. ERCC1 and XPA proteins were detected with anti-ERCCl and anti-XPA polyclonal antibodies, respectively, and with horseradish peroxidase (HRP)-conjugated protein A using the Renaissance Western Blot Chemiluminescence Kit (Dupont, Boston, MA). The anti-ERCCl antibody RW17 was made by immunizing a rabbit against purified recombinant ERCC1 protein expressed in Escherichia coli cells (Biggerstaff el al., 1993; Aboussekhra el al, 1995) . The anti-XPA antibody was kindly supplied by Dr K.Tanaka, Osaka University, Japan. 
For immunoprecipitation, ~10
7 cells prclabelled with 20 nCi/ml [ 35 S]methionine for 18 h were lysed with NP-40 buffer consisting of 10 mM Tns-HC1 (pH 7.2), 150 mM NaCl, 1% NP^M), 5 mM EDTA, 20 000 U/ml Trasylol and 10 mM PMSF. The cell extract (1 mg) was incubated with 5 |il antiERCCl antibody for 1 h at 4°C and further incubated with 80 ul protein ASepharose (Pharmacia, Uppsala, Sweden) for 1 h at 4*C. Immunoprecipitates bound to the protein A-Sepharose were separated by electrophoresis in 7.5% SDS-polyacrylamide gels. The gel was dried and co-immunoprecipitated proteins were visualized on X-ray films by fluorography.
To see whether the XPA protein is co-immunoprecipitated with the ERCCl protein, unlabelled cell extracts were incubated with the anti-ERCCl antibody and then with protein A-Sepharose as described above. Immunoprecipitates were separated by electrophoresis in 7.5% SDS-polyacrylamide gel and transferred to the membrane. The ERCCl and XPA proteins were detected by the same method as the immunoblot.
Results and Discussion
The ERCCl protein (31 kDa) migrates on SDS-PAGE at -43 kDa and was detected by immunoblotting (Figure 1 ). Abnormal migration on SDS-PAGE is observed in many proteins and is usually associated with a high proportion of charged amino acids. Among normal human, XP-A, D and G cell strains that had been transformed by Epstein-Barr virus or Simian Virus 40 (Figure la) , only XP2YO(SV) (XP-F) cells showed a markedly lower level of the ERCCl expression than other cell strains. To see whether this is specific to the XP2YO(SV) cell strain or is a frequent feature of XP-F cell strains, the level of ERCCl was examined in four other diploid XP-F cell strains (Figure lb) . The amount of ERCCl was extremely low in all the diploid XP-F cell extracts in comparison with extracts from normal human, XP-A and C diploid cell strains. Densitometry showed that the ERCCl band intensity of XP2YO(SV) (XP-F) cells was only 1/34 of the intensity of GM1953 (normal) cells and that the average ERCCl band intensity of 4 diploid XP-F cell strains was 1/5 and 1/8 of the intensity of KOWA (Normal) and XP1MG (XP-A) cell strains, respectively. (Figure 2a) . The 120 kDa band of XP2YO(SV) (XP-F) cells was markedly weaker than that of normal human, XP-A, C, D and G cell strains. Proteins co-immunoprecipitated with ERCCl were also examined in cell extracts from diploid strains (Figure 2b) . The 120 kDa bands were weaker in cell extracts from all the diploid XP-F strains than in those from normal, XP-A and C cell strains. Since many non-specific cross-reacting bands appeared in cell extracts from the diploid strains, probably due to a low fraction of actively proliferating cells, the 120 kDa band intensity of the diploid strains was normalized to the cross-reacting 90 kDa band intensity in each lane by densitometry. The average 120 kDa band intensity of 4 diploid XP-F cell strains was 1/8 of the intensity of KOWA (normal) and The immunoprecipitated ERCC1 protein was also analysed by immunoblotting (Figure 3a) . The ERCC1 content in XP-F cell strains was 2/3-1/10 of the content in normal, XP-A and C cell strains by this method, although the differences in the amounts were not as large as those shown in Figure lb . This shows that a low but significantly detectable amount of the ERCC1 protein, capable of being enriched by immunoprecipitation, exists in extracts from all tested XP-F cell strains.
The XPA protein could not be detected by an anti-XPA antibody in the anti-ERCCl immunoprecipitates of all cell strains on the same membrane of Figure 3a after removing the anti-ERCCl antibody (Figure 3b ), nevertheless the XPA protein was detected in all the cell extracts by the immunoblotting using the same antibody (Figure 3c ). The XPA protein was also not co-immunoprecipitated with the ERCC1 protein by the anti-ERCCl antibody in extracts of UV-irradiated human cells (data not shown). These data are in agreement with findings made using other anti-XPA antibodies (I.Kuraoka and K.Tanaka, personal communication). An interaction of XPA and ERCC1 has been detected by two-hybrid protein interaction (Li etai, 1994) , glutathione 5-transferase (GST)-fusion protein pull-down (Nagai et ai, 1995) and XPA affinity column chromatography (Park and Sancar, 1994) . These techniques are capable of detecting very weak interactions. Our results indicate that the XPA protein does not bind strongly enough to ERCC1 in cells to be detected in anti-ERCCl immunoprecipitates. Other factors including the XPF protein may modulate ERCC1-XPA binding in cells.
These results demonstrate that low content of ERCC1 and the 120 kDa protein is a frequent feature of fibroblast cells derived from XP-F patients. There is a report showing that a normal level of ERCC1 mRNA is transcribed in XP2YO (XP-F) cells (Van Duin et ai, 1989) , and no evidence of low level translation of ERCC1 in XP-F cells has been presented. Most probably, the ERCC1 protein binds to the 120 kDa protein in normal cells, but it is unstable without the 120 kDa protein in XP-F cells. A similar protein instability due to lack of a binding partner protein has been reported in some protein complexes such as cyclin D/CDK4 (Matsushime et ai, 1994) and Ku7O/8O (Chen et ai, 1996) . By analogy with the molecular weight of the RadlO (24 kDa) and Radl (126 kDa) complex in S.cerevisiae and that of their homologues swilO (29 kDa) and radl6 (107 kDa) in Schizosaccharomyces pombe, ERCC1 (31 kDa) can be predicted to bind to a protein in human cells of size consistent with the 120 kDa polypeptide coimmunoprecipitated with ERCC1 in this study. The 120 kDa protein seems likely to be a human homologue of S.cerevisiae Radl and S.pombe radl6 and the XPF/ERCC4 gene product.
A complete ERCC1 deletion causes a very severe phenotype in mice, with death before weaning (McWhir et ai, 1993) . It is thus possible that a complete loss of ERCC1 or its 120 kDa protein partner would not be compatible with human viability. This can be clarified in detail using purified XPF protein and antibody after the XPF/ERCC4 gene has been isolated. During the reviewing process of this manuscript, cDNA that complements DNA repair deficiency of RCG4 and XP-F cells has been reported (Brookman et ai, 1996; Sijbers et ai, 1996) .
